Oxytocic Pharmaceuticals Market
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Oxytocic</strong> <strong>Pharmaceuticals</strong> <strong>Market</strong>: Global Industry Analysis and Forecast 2016 -<br />
2022<br />
Persistence <strong>Market</strong> Research Released New <strong>Market</strong> Report on “<strong>Oxytocic</strong> <strong>Pharmaceuticals</strong><br />
<strong>Market</strong>: Global Industry Analysis and Forecast 2016 - 2022”.<br />
<strong>Oxytocic</strong> are the type of drugs used at the end of pregnancy, during labor pain and post-delivery<br />
which induce to take a selective action on the contraction of smooth musculature of the uterus.<br />
<strong>Oxytocic</strong> drugs are used is various field of obstetrics such as induction of labor, treatment of<br />
labor arrest, contraction stress test, management of labor and for the treatment of uterine atony<br />
and postpartum hemorrhage. The drug is also used to abort the fetus in case of miscarriage.<br />
For the prevention of uterine atony, oxytocic drugs are given following C-section. Synthetic<br />
derivatives of oxytocin can induce antidiuretic activity owing to absence of vasopressin.<br />
Increasing in the trend of delivery in hospitals over at home and number of caesarian<br />
procedures are the primary factor for the growth of oxytocic pharmaceuticals market. Also, the<br />
various type of products offering by various companies related to oxytocic drug to capture the<br />
market share is creating a competition for oxytocic pharmaceuticals market. The side effects<br />
associated with the oxytocic drugs leading to excessive bleeding following vaginal delivery due<br />
to postpartum haemorrhage are the key factors restraining the growth of oxytocic<br />
pharmaceutical market.<br />
The oxytocic pharmaceuticals market has been classified on the basis of product, application,<br />
end use and geography.<br />
<strong>Oxytocic</strong> <strong>Pharmaceuticals</strong> <strong>Market</strong> by Treatment type:<br />
<br />
<br />
<br />
Pre-eclampsia/Eclampsia<br />
Postpartum Hemorrhage<br />
Others<br />
<strong>Oxytocic</strong> <strong>Pharmaceuticals</strong> <strong>Market</strong> by End use type:<br />
<br />
<br />
<br />
Hospitals<br />
Maternity Centre<br />
Clinics<br />
Postpartum haemorrhage (PPH) is the key factor that led to maternal mortality which is a type of<br />
obstetric haemorrhage. According to WHO, there are 14 million cases related to PPH occur<br />
every year. PPH oxytocin injection is recommended for treatment of PPH. The recommended<br />
dose for oxytocic pharmaceuticals is 1-2mU/min. Various brands that are available in the market<br />
Persistence <strong>Market</strong> Research 2
Change language